European Medicines Agency Grants Orphan Drug Designation to Annamycin in AML

The European Medicines Agency has granted orphan drug designation to annamycin for the treatment of patients with acute myeloid leukemia.

Related Keywords

United States ,Walter Klemp ,Trademark Office ,European Medicines Agency ,Moleculin Biotech Inc ,Moleculin Biotech ,Medicines Agency ,